{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-24-000125","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.171191+00:00","generated_at":"2026-06-02T23:02:49.254620+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Rapid Micro Biosystems Q1 revenue $5.6M (+11% YoY), loss $13.3M; reaffirms FY guidance","bullets":["Q1 revenue $5.6M (+11% YoY); net loss $13.3M ($0.31/share).","Recurring revenue $3.7M (+15% YoY); record consumable revenue.","Placed three Growth Direct systems; reaffirms FY2024 revenue guidance of at least $27M.","Cash, equivalents and investments $79.5M; no debt; runway into H2 2026.","Growth Direct Rapid Sterility platform on track for mid-2024 launch."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-24-000125","json":"https://secwatch.observer/filing/0001380106-24-000125.json","markdown":"https://secwatch.observer/filing/0001380106-24-000125.md","text":"https://secwatch.observer/filing/0001380106-24-000125.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010624000125/0001380106-24-000125-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010624000125/rpid-20240503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:02:49.254620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"307ddfd3443d9d875940fec7245785d0fca07b18","claim":"RAPID MICRO BIOSYSTEMS, INC. reported first quarter ended March 31, 2024 results: revenue $5.6 million, net income $13.3 million, EPS $0.31. Guidance reaffirmed.","evidence_excerpt":"Rapid Micro Biosystems Reports First Quarter 2024 Financial Results Reports first quarter 2024 total revenue of $5.6 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010624000125/0001380106-24-000125-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$5.6 million"},{"label":"Net income","value":"$13.3 million"},{"label":"EPS","value":"$0.31"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}